Bringing the fundamentals into focus…
Back to Puma Biotechnology, Inc.
How Puma Biotechnology, Inc. stacks up
PBYI · against 463 other Healthcare companies of similar size
Profitability
90/ 100
Near the top of its peers.
Ranked #31 of 464 · scores higher than 93% of peers
Bars: peers in each 10-point band of the profitability score35 peers with a profitability score of 90–100, including PBYI · Click a bar to see the companies
Why profitability scores 90?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its return on assets, return on invested capital and operating margin, which are stronger than most Healthcare peers.
- a wider operating margin: stronger than 68% of peers. Operating margin: 13.2% vs peer median 7.1%
- a higher return on invested capital: stronger than 89% of peers. Return on invested capital: 23.6% vs peer median 4.7%
- a higher return on assets: stronger than 94% of peers. Return on assets: 13.9% vs peer median 1.7%
Metric by metric
Position: dot = PBYI, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | PBYI | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 438 reported | 23.6% | 2.0% | 91% | 33% | |
| Operating marginHigher is better · 434 reported | 13.2% | 4.9% | 77% | 33% | |
| Return on assetsHigher is better · 460 reported | 13.9% | 0.9% | 97% | 33% | |
| Return on equityHigher is better · 440 reported | 22.0% | 1.2% | 96% | Context only | |
| Gross marginHigher is better · 480 reported | 74.8% | 40.0% | 84% | Context only |
Ranking by profitability score
Top 5 and the companies ranked around PBYI| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 595M USD | 99 | 97 | |
| 1 | 433M USD | 99 | 81 | |
| 1 | 578M USD | 99 | 73 | |
| 1 | 914M USD | 99 | 81 | |
| 1 | 609M USD | 99 | 91 | |
| 31 | 3.7B HKD (≈$471M) | 90 | 69 | |
| 31 | 2.7B CNY (≈$377M) | 90 | 77 | |
| 31 | 344M USD | 90 | 54 | |
| 31 | 810M USD | 90 | 69 | |
| 31 | 528M USD | 90 | 58 | |
| 36 | 4.7B HKD (≈$606M) | 89 | 75 | |
| 36 | 3.6B CNY (≈$506M) | 89 | 65 | |
| 36 | 31.1B TWD (≈$965M) | 89 | 63 | |
| 39 | 3.4B CNY (≈$480M) | 88 | 74 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score